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 Bacterial siderophores are a class of small organic compounds that are produced 
endogenously by bacteria to chelate essential ferric iron from their surroundings. Because 
the bioavailability of ferric iron is extremely low is physiological pH, the host of a 
parasitic infection can be a poor source of soluble Fe3+. Consequently, bacteria rely upon 
siderophore transport systems to efficiently scavenge the nutrient. Nearly every bacterial 
species ever isolated has evolved a set of unique enzymatic pathways for de novo 
synthesis of these compounds, thus exists an inimitable relationship between a genus or 
species of bacteria and the siderophores it produces.  
 Our goal was to exploit the highly-refined interaction that takes place between a 
siderophore and its corresponding membrane-bound transporter by utilizing it as means 
to capture and identify a pathogen more rapidly and economically than standardized PCR 
methodology. To achieve this, we developed a robust lab-on-a-chip device that consists 
of a surface-mounted siderophore that is capable of capturing its cognate pathogen with a 
high degree of accuracy. With this device, bacterial capture occurred in a predetermined 
pattern, and was verified using a benchtop light microscope. This simple and relatively 
inexpensive method of pathogen detection may allow for widespread use of the device, 




 Until recently, researchers have obtained siderophores for research using 
complicated, time-consuming techniques that involve isolating siderophore from large 
bacterial supernatants followed by extensive purification. Our goal was to avoid 
disadvantages associated with siderophore isolation methodology by chemically 
synthesizing siderophores. This would allow us to circumvent the use of potentially 
hazardous biologics while simultaneously improving product yield and drastically 
simplifying the purification process. The following work describes an improved approach 
for chemical synthesis of petrobactin, a Bacillus anthracis siderophore, as well as the first 
chemical synthesis of staphyloferrin A (SA), a siderophore of Staphylococcus aureus. We 





CHAPTER 1. AN IMPROVED SYNTHESIS OF PETROBACTIN, A BACILLUS 
ANTHRACIS SIDEROPHORE 
1.1 Abstract 
 A B. anthracis siderophore, petrobactin, was synthesized chemically with 65% 
total yield. The synthesis includes application of a novel amide-ester exchange reaction 
using Sb(OEt)3 under neat conditions, which considerably improved the chemical yield of 
functional petrobactin when compared to other reported syntheses. 
 
1.2 Introduction 
Petrobactin, 1, is an iron-chelating siderophore produced by pathogenic bacterium 
Bacillus anthracis (see figure 1.1).1 It has been shown to be a high-affinity scavenger of 
sparingly-soluble ferric iron from the extracellular environment of a B. anthracis 
infection.2-4 Since human pathogens require iron as an essential nutrient, the 
reinternalization of the ferrisiderophore complex is crucial to the survival of the bacterial 
cell.5, 6 
 In order to study siderophore-based iron acquisition systems of B. anthracis in the 
most efficient manner possible, the availability of research quantities of petrobactin 
becomes a legitimate concern. Typically, siderophores are isolated from supernatants of 
bacterial cultures and purified several times to obtain a product worth of research.7 




extract from large cultures of bacteria to obtain appreciable amounts of the material. 
When dealing with highly pathogenic B. anthracis, siderophore isolation methodology 
can pose significant health risks to researchers.8  
In order to address these problems, members of the scientific community have 
since devised methods to produce petrobactin utilizing both enzymatic and chemical 
synthesis techniques.9-13 These techniques, however, involve difficult, inefficient 
reactions that require refining in order to improve overall petrobactin yield. Consequently, 
we chose to undertake the task of optimizing petrobactin chemical synthesis so 





1.3    Experimental Section 
 
1.3.1    Chemicals and Materials 
 Spectrograde solvents were used without further purification. Anhydrous DCM, 
DMSO, DMF, EtOAc, MeOH, H2SO4, methanesulfonyl chloride, 3-(dibenzylamino)-1-
propanol, N-Boc-1,4-butanediamine, 3,4-dihydroxybenzoic acid, PhSiH3, DIPEA, TEA, 
triphenylphosphine, and (Ph3P)4Pdo were purchased from Sigma Aldrich (St. Louis, MO). 
Antimony (III) ethoxide was purchased from ProChem, Inc. (Rockford, IL). PyBOP was 
purchased from GenScript (Piscataway, NJ).  
 
1.3.2    Equipment 
 All NMR spectra were recorded on either 400 MHz Varian or 500 MHz Bruker 
spectrometers. 
 
1.3.3    Synthesis of 3-(dibenzylamino)propyl methanesulfonate (3) 
 Methanesulfonyl chloride was added dropwise to the cooled solution of 3-
(dibenzylamino)-1-propanol (2) and TEA in DCM. The mixture was stirred at 0oC. After 
completion of the reaction (2 h) water was added and the crude mixture was extracted 
with DCM, washed with brine, dried over anhydrous Na2SO4 and concentrated. The 
residue was purified by column chromatography (NH- silica gel, hexanes/EtOAc 9.5:0.5) 






1.3.4    Synthesis of tert-Butyl (4-((3-(dibenzylamino)propyl)amino)butyl)carbamate (5) 
 A mixture of 3, N-Boc-1,4-butanediamine (4) and DIPEA in dry DMSO was 
stirred at 80oC under nitrogen environment for 24 h. The reaction was quenched with 
water. The layers were separated and the aqueous layer was extracted several times with 
EtOAc. The organic layers were combined, washed with brine, dried over Na2SO4, and 
concentrated. The concentrated residue was purified by column chromatography (NH- 
silica gel, hexanes/EtOAc 9.5:0.5 to 7:3) to afford 5 as a colorless gum. 
 
1.3.5    Synthesis of tert-butyl (4-((3-aminopropyl)amino)butyl)carbamate (6) 
 A mixture of 5 and Pd/C (10%) in ethanol was refluxed under H2(g) for 4 h. The 
suspension was filtered over celite and the filtrate was concentrated to give the crude 
product, 6, which was used in the next step. 
 
1.3.6    Synthesis of methyl 3,4-bis(benzyloxy)benzoate (9) 
 To a solution of 3,4-dihydroxybenzoic acid (7) in MeOH was added a catalytic 
amount of concentrated H2SO4 and the mixture was refluxed for 8h. The reaction mixture 
was cooled to room temperature and solvent was removed by rotary evaporation. The 
remaining residue was dissolved in EtOAc and washed with saturated NaHCO3 and brine. 
The combined extract were dried over Na2SO4, and concentrated to give the crude methyl 
ester 8.  To the residue was added a solution of benzyl bromide and K2CO3 in DMF. The 
mixture was heated at 120oC. After 36 h, the reaction mixture was cooled to ambient 




to remove K2CO3. The mixture was extracted with EtOAc 3 times. The organic layers 
were washed with ice-cold 1 M HCl, water, brine, dried over Na2SO4, and concentrated. 
The residue was purified by column chromatography (silica gel, hexanes/EtOAc 9.5:0.5) 
to afford 9 as a colorless gum. 
 
1.3.7    Synthesis of tert-Butyl (4-((3-(3,4-
bis(benzyloxy)benzamido)propyl)amino)butyl)carbamate (10) 
 
 To a mixture of 6, 9 was added with Sb(OEt)3 in neat conditions at room 
temperature and the flask was purged with N2(g). The mixture was heated at 80oC for 24 
h. After cooling to room temperature, the mixture was quenched with MeOH and filtered 
through pad of celite using CHCl3, MeOH, then i-PrNH2. The resulting filtrate was 
concentrated with a rotary evaporator and the resulting residue was purified by column 
chromatography on Cromatorex®-NH-DM1020 silica gel using a mixture of 
EtOAc:MeOH (100:0 to 100:1) as a mobile phase to give 10. 
 
1.3.8    Synthesis of N-(3-((4-aminobutyl)amino)propyl)-3, 
4-bis(benzyloxy)benzamide (11) 
 
 TFA was added dropwise to the cooled solution of 10 in DCM. The mixture was 
stirred at 0oC. After completion of reaction (2 h), reaction mixture was concentrated and 








1.3.9    Synthesis of 2-tert-Butyl-1,3-di-N-(hydroxyl)-Succinimidyl Citrate (13) 
 13 was synthesized in 4 steps from citric acid (12) according to previously 
described procedures.15 
 





 11 was dissolved in dioxane and DCM and TEA was added to the stirring flask to 
facilitate deprotection of the TFA salt. 13 was then added to the flask and the reaction 
was allowed to proceed for 1.5 h after which the solvent was removed by rotary 
evaporation. The residue was dissolved in EtOAc and extracted 3 times with H2O. The 
organic layer was isolated and dried over MgSO4. The mixture was filtered through 
cotton and the filtrate was concentrated using rotary evaporation to yield 14. 
 
1.3.11    Synthesis of Petrobactin (1) 
 14 was dissolved in DCM/H2O (100:1) and the mixture was cooled to 0°C. TFA 
was added to the solution and the reaction was allowed to warm to room temperature. 
After 2 h, the solvent was removed by rotary evaporation, and placed under high vacuum 
to ensure complete removal of TFA. Benzylated petrobactin was recovered and 
redissolved in a mixture of AcOH/H2O (20:1) in a flask purged with H2. 10% Pd/C was 
added to the flask and the reaction was stirred for 2h under H2. The mixture was filtered 




layer was neutralized with 1M K2CO3 and the resulting solution was lyophilized to yield 
petrobactin (1). 
 
1.4  Results and Discussion 
 To synthesize 1 (see figure 1.1), we designed a convergent synthesis using 3 
building blocks that were individually modified and protected for later assembly. In order 
to prepare the first building block, outlined in Scheme 1.1, we started with commercially 
available 2, which was O-mesylated, providing the terminal hydroxyl with an adequate 
leaving group for subsequent nucleophilic substitution. The mesylated product, 3, was 
reacted with the mono-protected diamine, 4, to yield a protected version of the first 
building block, compound 5. In order to deprotect the terminal amine group, a 
debenzylation reaction was performed using catalytic hydrogenation to yield 6 as a free 
primary amine. 
 Scheme 1.2 demonstrates preparation of the protected dihydroxybenzoic acid 
moeity required for petrobactin synthesis. Commercially available 7 was refluxed in 
H2SO4/MeOH to esterify the aryl carboxylic acid, yielding 8. The catechol component of 
compound 8 was then protected using benzyl bromide to produce compound 9. 
 Assembly of these two building blocks was performed in the first step of Scheme 
1.3, where 6 and 9 were coupled using Sb(OEt)3 by heating the reaction in neat 
conditions . This important step in petrobactin synthesis notoriously produces low-yields 
of 10 using standard peptide-coupling reagents, so we modified the reaction to include a 
high-yielding Sb(OEt)3-mediated ester amide transformation reaction based on 
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CHAPTER 2. CHEMICAL SYNTHESIS OF STAPHYLOFERRIN A AND ITS 
EVALUATION FOR USE IN A PATHOGEN-DETECTION DEVICE 
2.1 Abstract 
 Siderophores are unique molecules that can be used to capture bacteria that 
express a specific receptor for them. In order to test this hypothesis, we synthesized a 
siderophore unique to S. aureus called staphyloferrin A, and stamped it in a distinctive 
pattern on a gold chip using microcontact printing. Upon introduction of the chip to a 
solution containing S. aureus, capture of the pathogen was witnessed within the confines 
of pattern where SA was stamped. These experiments provide evidence of an interaction 
that occurrs between S aureus and SA. These findings are significant because they imply 
that siderophores are capable of capturing bacteria on a small device that can be imaged 
using optical microscopy. 
 
2.2 Introduction 
S. aureus is a gram-positive bacterium that commonly resides on human epithelial 
tissues and nasal mucosa. It is a community microbe that thrives in environments with 
unsanitary conditions, and is believed to be a primary causative factor of an estimated 
500,000 surgical site infections of hospital patients in the United States alone.17 Among 




resistant mutants of S. aureus that require rigorous and potentially toxic treatment 
regimens.18-20  
In order to effectively treat nosocomial pathogens like S. aureus, we must focus our 
priorities on early detection. The ability to diagnose communicable diseases in the early 
stages of progression is a powerful tool we have against prohibiting rapid transmission of 
the disease throughout exposed populations. Diagnosis involves isolation of the bacteria, 
pre-enrichment, and characterization using RT-PCR, a process that consumes a 
significant amount of time that could be spent treating the patient and preventing disease 
communication.21  
To expedite the process of pathogen detection and identification, we have 
developed a device with the sole purpose of specifically capturing S. aureus. It is a lab-
on-a-chip device that can be imaged with a benchtop optical microscope at low 
magnification.22, 23 The device was designed to allow for clear distinction between a 
blank chip and a chip containing captured bacteria. With dark field microscopy, the 
bacteria can be easily detected as they scatter light and appear as bright yellow spots 
against a black background. 
It is exceedingly important that this device is able to capture S. aureus with a high 
degree of specificity, since the capturing of other strains of bacteria can give misleading 
data to clinicians, which can effectively lead to disease misdiagnosis and subsequent 
mistreatment. We attempted to overcome this problem by taking advantage of a particular 
interaction that occurs between the ABC transporter HtsA, located on the outer 




Siderophores are small organic chelators that bacteria biosynthesize and release 
into their extracellular environment for sequestration of ferric iron.27 The iron-
siderophore chelate is reinternalized by bacterial cells using a specialized receptor 
complex. Once inside the cell, Fe(III) is reduced to Fe(II) and released from the 
siderophore to be incorporated into essential metabolic processes.28 Herein, we wish to 
report on the methods developed to chemically synthesize SA using SPPS, and the 
implementation of the siderophore in a pathogen detection device.22 
 
2.3 Experimental Section 
 
2.3.1    Chemicals and Materials 
Fmoc-D-Ornithine(Alloc)-OH was purchased from Iris Biotech (Marktredwitz, 
Germany). Dichloromethane (DCM), methanol (MeOH), and dimethylformamide (DMF) 
were purchased from Mallinckrodt Baker (Phillipsburg, NJ). Triphenylphosphine (PPh3), 
tetrahydrofuran (THF), diisopropyl azodicarboxylate, Stratospheres™ PL-Wang resin, 
piperidine, diisopropylethylamine (DIPEA), phenylsilane (PhSiH3), 
tetrakis(triphenylphosphine)palladium ((Ph3P)4Pd0), citric acid, trifluoroacetic acid (TFA), 
iron(III) chloride, bovine serum albumin (BSA),  phosphate-buffered saline (PBS), and 
2,2’-bipyridine were purchased from Sigma-Aldrich (Saint Louis, MO). Benzotriazol-1-
yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP) was purchased from 
GenScript (Piscataway, NJ). 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) was 




2.3.2    Equipment 
All solid-phase synthesis reactions were performed in a solid-phase peptide 
synthesis vessel from Chemglass Life Sciences (Vineland, NJ). Hilic Atlantis Silica 
HILIC OBD Preparative HPLC column was purchased from Waters Corporation 
(Milford, MA). Gold surface plasmon resonance (SPR) chips were purchased from 
Reichert Technologies (Depew, NY). All images were taken with an Olympus BX43 
LED Upright Microscope. 
 
2.3.3    Synthesis of Staphyloferrin A22 
Fmoc-D-Orn(Alloc)-OH and triphenylphosphine were added to DCM:THF (1:1), 
and the solution was cooled to 0°C in an ice bath. DIAD was added dropwise to the 
solution to prevent generation of excess heat. The solution was then added to a SPPS 
vessel containing StratoSpheresTM PL-Wang resin, 100–200 mesh that was pre-swollen 
in DCM for 10 min prior to addition. Ar(g) was bubbled through the solution for 36 h, 
allowing maximum loading of the residue onto the resin. The solution was removed from 
the SPPS vessel and the resin was washed with 3 x 5 mL DCM, 3 x 5 mL THF, 3 x 5 mL 
DMF, and 3 x 5 mL DCM. The resin was treated with a solution of 20% piperidine in 
DMF to remove the N-terminal Fmoc (3 x 5 mL) over the course of 30 minutes. The 
Fmoc-cleavage solution was drained from the vessel and the resin was washed with 3 x 5 
mL DMF. After verifying the presence of a primary amine on the residue with a Kaiser 
test, a solution of 3-t-Bu-citrate,15 PyBOP, and DIPEA in 4 mL DMF was introduced to 
the vessel. The reaction was bubbled with Ar(g) for 12 h. After removing the coupling 




DCM , a Kaiser test was used to determine completion of the reaction by signifying the 
lack of a free primary amine on the resin. Next, a solution of (Ph3P)4Pd0 and PhSiH3 in 
DCM was added to the resin to remove Alloc from the ornithine amine. The reaction was 
allowed to bubble with Ar(g) for 2 h, the solution was drained, and the resin was washed 
with 3 x 5 mL DCM, 3 x 5 mL DCM:DIPEA (19:1), 3 x 5 mL DMF, and 3 x 5 mL DCM. 
A positive Kaiser test affirmed the presence of a primary amine on the resin. A solution 
of 3-t-Bu-citrate, PyBOP, and DIPEA in DMF was introduced to the vessel. The reaction 
was bubbled with Ar(g) for 12 h to ensure reaction completion. After removing the 
coupling solution from the vessel, the resin was washed with 3 x 5 mL DMF, 3 x 5 mL 
MeOH, and 3 x 5 mL DCM. A negative Kaiser test indicated that the reaction had 
reached completion. In order to cleave SA from the resin and simultaneously deprotect 
tert-butyl groups present on citrate moieties, a solution of 92.5% TFA, 2.5% DCM, 2.5% 
H2O and 2.5% TIPS was added to the vessel and allowed to bubble with Ar(g) for 1 h. 
The cleavage solution was drained into a round bottom flask, and combined with two 
additional portions of the cleavage solution used to wash the resin remaining in the vessel. 
The cleavage solution was concentrated under reduced pressure to approximately 2 mL, 
making certain to avoid heating the solution beyond 40° C while evaporating.10 To the 
concentrate was added diethyl ether and the precipitate was collected by centrifugation. 
After decanting the supernatant, the precipitate was washed with diethyl ether and 
centrifuged three additional times to remove any remaining ether-soluble components. 
The precipitate was dried under high vacuum to yield the crude mixture of diastereomers 
as white powder. The material was purified by preparative HPLC using an Atlantis Silica 




7) and acetonitrile mobile phase yielding two chromatographically distinguishable 
diastereomers of SA. 
 
2.3.4    Preparation of Staphyloferrin A-BSA Conjugate 
14 mmol of SA was dissolved in deionized water and gently stirred as a 0.2 M 
aqueous FeCl3 solution was added dropwise. The chelation reaction was allowed to stir 
for 5 min and lyophilized. In order to prepare “ink” used for PDMS stamping, 96 μmol of 
EDC was combined with 28 μmol of staphyloferrin A-Fe in 375 μL of pH 7.4 PBS. This 
mixture was stirred at room temperature for 30 minutes to activate the ornithine 
carboxylate. A 1 mL solution of 0.9 mmol (60 mg) BSA in PBS was prepared and added 
to the reaction and stirred for an additional 2 h. After completion of the reaction, the 
mixture was filtered using 0.45 μm membrane filter. The filtrate was collected and either 
used for immediate PDMS stamping, or lyophilized for later use. 
 
2.3.5    Preparation of Staphyloferrin A-BSA-patterned Chips 
To produce a PDMS stamp that will create a pattern visible by low magnification 
optical microscopy, a silicon wafer was etched with 20 μm wide parallel lines with 20 μm 
gaps using UV photolithography. The stamp was fabricated by pouring viscoelastic liquid 
PDMS over the silicon master and allowing it to cure. The hardened PDMS was 
henceforth able to be used for microcontact printing applications. To apply ink to the 
stamp, a cotton swab was dipped in 50 uL of SA-BSA ink, rolled onto the textured side 
of the PDMS, and allowed to dry in the inverted position after removing excess liquid 




pressed lightly for 10 seconds, and allowed to sit on top of the chip for an additional 5 
minutes. The stamp was carefully removed and the chip was sealed in a sterile Petri dish 
for 5 hours at 4°C. To block portions of the chip unstamped by the PDMS, a 5% (w/w) 
BSA solution was prepared in pH 7.4 in PBS and applied to the chip for 5 minutes. The 
BSA solution was removed with a sterile pipette and the chip was rinsed thoroughly with 
3 x 5 mL portions of pH 7.4 PBS. 
 
2.3.6    Growth of S. aureus 
A frozen stock of S. aureus was used to seed a growth culture in standard LB 
broth at 37°C on an orbital shaker overnight. 10 μL of the seed culture was transferred to 
low-iron LB media, which was prepared by adding 2,2′-bipyridine to a concentration of 
0.2 mM. The bacteria were grown to a concentration of 1 x 108 CFU/mL by measuring 
optical density at 600 nm with a spectrophotometer and diluted with pH 7.4 PBS to the 
appropriate concentration for experiments. 
 
2.3.7    Capture and Imaging of Chips 
 50 uL of 1 x 106 CFU/mL S. aureus was dispensed onto siderophore-stamped 
gold chips and incubated in a closed, sterile Petri dish for 1 h. The solution was removed 
with a sterile pipette and the chip was rinsed thoroughly with 3 x 5 mL pH 7.4 PBS and 
deionized water respectively. The chips were dried with a gentle stream of Ar(g) to 






2.4 Results and Discussion 
In order to exploit the receptor-ligand interaction that exists between SA and 
HtsA, we chose to design a synthesis scheme which allowed us to chemically produce SA. 
Prior to this study, the siderophore was obtained through isolation from live S. aureus, a 
laborious, time-consuming process requiring growth of a large amount of bacteria, 
extraction from the bacterial supernatant, and multiple purifications.29 By synthesizing 
SA, we are able to considerably simplify this process by using dependable and high-
yielding peptide-coupling strategies on solid-phase resin. Synthesizing the ligand on solid 
phase eliminates the need for purification after each reaction, a compulsory practice 
associated with conventional solution-phase syntheses. This approach also allows us to 
circumvent purification concerns associated with contamination from other chemically-
similar siderophores or small molecules produced by S. aureus that are normally present 
in a crude culture supernatant. 
 Scheme 2.1 demonstrates how SA can be methodically synthesized using SPPS 
techniques. After cleavage from the resin and HPLC purification, SA was chelated to 
Fe3+ and simultaneously reacted with BSA using traditional EDC-coupling techniques in 
an aqueous medium. 
A dilute solution of SA-BSA conjugate was stamped onto gold chips using a 
patterned PDMS stamp. Portions of the chip where the pattern was not present were 
blocked with BSA to ensure there was no reactive gold exposed on the chip. The chip 
was exposed to a solution of 106 CFU/mL S. aureus in order to examine its ability to 
capture the pathogen for the purpose of identification. The chip was later imaged using 




figure 2.1. When compared to images taken of the same chip prior to exposure to S. 
aureus, captured bacteria are readily observable as bright yellow clusters that contrast 
against the dark background of the chip. Since the SA-BSA conjugate was stamped in a 
specific pattern and the capture reflects this pattern, it is discernible that there is no 
observable interaction between S. aureus and BSA alone, but exclusively between the 
siderophore and its cognate receptor on the cell surface of the pathogen. 
 
2.5 Conclusion 
Though the siderophore-patterned chip shows promise as an effective means of 
pathogen capture and detection in these and other preliminary studies,23, 30 additional 
experiments are required to investigate the limit of detection, the specificity towards S. 
aureus versus other human pathogens, and the minimum amount of time required for 
discernable capture.  
We have learned that the chemical synthesis of SA and the production of the 
pathogen capture device are relatively inexpensive and straightforward processes. It can 
also be suggested that this method of pathogen detection may significantly reduce the 
amount of time required to assay for a specific strain of bacteria when compared to 
commonly accepted methods in the literature.31, 32 This is an exceedingly important 
characteristic for a pathogen detection system, since rapidly-communicable diseases can 
disseminate through a population in a very short period of time. In addition to these 
benefits, now that a simple, high-yielding chemical synthesis of SA has been developed, 
its other potential applications can be investigated without the need for time-consuming 




variety of other applications, ranging from its use as a constituent in targeted antibiotic 
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CHAPTER 3. SELECTIVE CAPTURE OF S. AUREUS USING IMMOBILIZED 
SIDEROPHORE STAPHYLOFERRIN A 
3.1 Abstract 
 The necessity for a quick and inexpensive diagnostic tool for bacterial disease has 
become increasingly essential as dangerous mutants arise through antibiotic resistance 
mechanisms and total eradication of some pathogenic strains remains difficult.17-19, 42, 43 
In order to address this problem, we developed a pathogen detection device that is 
capable of rapidly and specifically capturing S. aureus at concentrations as low as 1 x 102 
CFU/mL. This technology takes advantage of an innate high-affinity interaction that is 
present between HtsA, a membrane-bound transporter on S. aureus, and staphyloferrin A, 
a unique S. aureus siderophore called that has been immobilized on a gold chip.22, 26, 33 
 
3.2    Introduction 
 Population mobility is an increasingly important concern when it comes to the 
rapid spread of communicable diseases throughout the world. Advances in transportation 
technology have allowed us to quickly and easily translocate, dramatically increasing the 
probability of major disease outbreaks and pandemics.44 Consequently, researchers and 
clinicians must lead the movement to develop pathogen detection devices that are not 
only capable of specific pathogen identification, but are also inexpensive, simple to use, 




 To achieve this, we have constructed a lab-on-a-chip device consisting of an 
immobilized, S. aureus-specific ligand that captures the pathogen via a receptor-ligand 
interaction. The ligand, a siderophore called SA, is biosynthesized by S. aureus, and is 
released into the extracellular environment to sequester ferric iron, The ferrisiderophore 
complex is then reinternalized by the bacteria, where captured iron can be incorporated 
into essential intracellular redox processes.24-27, 34  
 Because there is a unique interaction between SA and HtsA, a membrane-
spanning ABC transporter responsible for uptake of the ferrisiderophore complex, we 
designed a lab-on-a-chip device that uses support-bound SA to capture S. aureus. The 
siderophore was loaded onto BSA, which was then reacted with the gold surface of the 
chip in a predetermined pattern specified by microcontact PDMS stamping. S. aureus can 
be captured by SA present on the chip, and the bacterial cells can be imaged using dark 
field microscopy. 
 After the first solid-phase chemical synthesis of SA was published by our 
laboratory in 2014,22 we chose to expand upon this procedure by adding a peptidic spacer 
(15) that should improve siderophore loading onto BSA and S. aureus capture efficiency. 
We also undertook the task of evaluating the siderophore’s ability to selectively capture 





3.3 Experimental Section 
 
3.3.1    Chemicals and Materials 
Fmoc-D-Ornithine(Alloc)-OH was purchased from Iris Biotech (Marktredwitz, 
Germany). Dichloromethane (DCM), methanol (MeOH), and dimethylformamide (DMF) 
were purchased from Mallinckrodt Baker (Phillipsburg, NJ). Triphenylphosphine (PPh3), 
tetrahydrofuran (THF), diisopropyl azodicarboxylate, Stratospheres™ PL-Wang resin, 
piperidine, diisopropylethylamine (DIPEA), phenylsilane (PhSiH3), 
tetrakis(triphenylphosphine)palladium ((Ph3P)4Pd0), citric acid, trifluoroacetic acid (TFA), 
iron(III) chloride, bovine serum albumin (BSA),  phosphate-buffered saline (PBS), and 
2,2’-bipyridine were purchased from Sigma-Aldrich (Saint Louis, MO). Benzotriazol-1-
yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP) was purchased from 
GenScript (Piscataway, NJ). 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) was 
purchased from Bio-Rad (Hercules, CA). 
 
3.3.2    Equipment 
Solid-phase peptide synthesis vessels from Chemglass Life Sciences (Vineland, 
NJ) were used in all solid-phase synthesis reactions. Atlantis Silica HILIC OBD 
Preparative HPLC column was purchased from Waters Corporation (Milford, MA). Gold 
surface plasmon resonance (SPR) chips were purchased from Reichert Technologies 






3.3.3 Synthesis of 1522 
 To a SPPS vessel containing 2-chlorotrityl resin pre-loaded with H-Cys(Trt), 
DCM was added and bubbled with N2(g) to swell the resin. The solvent was drained, and 
a solution of 20% piperdine in DMF was added to the vessel and bubbled for 30 min to 
remove the terminal Fmoc. The solution was drained and the resin was washed with 3 x 5 
mL DMF, 3 x 5 mL MeOH, and 3 x 5 mL DCM. A solution of Fmoc-L-Asp(OtBu)-OH, 
PyBOP, and DIPEA in DMF was added to the vessel and bubbled with N2(g) for 5 h. The 
reaction mixture was drained and the resin was washed with 3 x 5 mL DMF, 3 x 5 mL 
MeOH, and 3 x 5 mL DCM. This process of Fmoc deprotection, peptide coupling, and 
extensive washing was repeated with the following residues: Boc-L-Dap(Fmoc)-OH, 
Fmoc-Glu(OtBu)-OH, Fmoc-D-Orn(Alloc)-OH and the first 3-tBu-citrate moiety. A 
solution of (PPh3)4Pdo and PhSiH3 in DCM was then added to the reaction vessel to 
deprotect the Alloc-protected ornithine amine. The resin was washed and reacted with the 
second 3-tBu-citrate moiety using the same conditions as prior peptide couplings. To 
cleave compound 1 from the resin, a solution of 95 % TFA, 2.5% ethanedithiol, and 2.5% 
TIPS was added to the resin and bubbled with N2(g). The cleavage mixture was collected 
and concentrated by rotary evaporation at room temperature.10 A white powder was 
precipitated from the crude concentrate using diethyl ether and the precipitate was 
washed with additional portions of diethyl ether. The white powder was purified by 
HPLC using a Waters Atlantis Silica HILIC OBD Preparative HPLC column with 10 






3.3.4 Synthesis of 15-BSA conjugate 
Refer to section 2.3.4 for details. 
 
 
3.3.5 Preparation of 15-BSA-patterned chips 
See figure 3.2 and section 2.3.5 for details. 
 
 
3.3.6    Growth of S. aureus 




3.3.7    Capture and Imaging of Chips 
 
3.3.7.1    Evaluation of Limit of Detection 
 50 μL of S. aureus in pH 7.4 PBS was dispensed onto siderophore-patterned gold 
chips in a sterile Petri dish at 1 x 106, 1 x 105, 1 x 104, 1 x 103, or 1 x 102 CFU/mL and 
incubated for 1 h. The chips were then washed with 3 x 5 mL pH 7.4 PBS and 3 x 5 mL 
deionized water to remove any unbound bacteria from the chip. The chips were then 
imaged using dark field microscopy at 40x magnification. 
 
3.3.7.2    Time-Course Study 
 50 μL of 1 x 106 CFU/mL S. aureus in pH 7.4 PBS was dispensed onto 
siderophore-patterned gold chips in a sterile Petri dish and incubated for the following 
times: 5 min, 30 min, 1 h, 2 h. Afterwards, the chips were washed with 3 x 5 mL pH 7.4 
PBS and 3 x 5 mL deionized water to remove any unbound bacteria from the chip. The 












3.3.7.3    Evaluation of Chip Specificity 
 50 μL of pH 7.4 PBS containing 1 x 106 CFU/mL S. aureus, E. coli, P. aeruginosa, 
S. flexneri, V. cholerae, Y. enterocolitica, or S. enterica was dispensed onto siderophore-
patterned gold chips in a sterile Petri dish and incubated for 1 h. Afterwards, the chips 
were each washed with 3 x 5 mL pH 7.4 PBS and 3 x 5 mL deionized water to remove 
any unbound bacteria from the chip. The chips were imaged using dark field microscopy 
at 10x magnification. 
 
3.4    Results and Discussion 
 
 Compound 15 was produced using established solid-phase synthesis techniques, 
and the synthetic scheme we developed was based on a similar synthesis of SA published 
by our laboratory in 2014.22 Our recent findings have provided us with insight on how to 
produce high yields of enantiomerically pure 15 (see figure 3.1).  
 Beginning with preloaded H-Cys(Trt)-2-chlorotrityl resin, we systematically 
added Fmoc-L-Asp(OtBu)-OH, Boc-L-Dap(Fmoc)-OH, and two Fmoc-Glu(OtBu)-OH 
residues to the resin respectively using SPPS strategies. SA was modularly synthesized at 
the N-terminus of the peptidic spacer with addition of differentially deprotectable Fmoc-
Orn(Alloc)-OH and two 3-t-Bu-citrate residues. Compound 15 was cleaved from the 
resin, purified by HPLC, and used in pathogen detection studies in order to assess its 
ability to capture S. aureus. 
 To expand upon previously-published pathogen capture studies conducted using a 




7.4 PBS. This solution was used as ink for microcontact printing in order to produce a 
specific pattern of 15-BSA on a gold chip according to figure 3.2 below. The pattern, 
imprinted on a PDMS stamp from a silicon master, consists of raised 20 μm wide lines in 
parallel with 20 μm gaps, producing a recognizable pattern that is observable with low-
magnification optical microscopy.  
 After stamping, the gold chips were blocked with a solution of unlabeled BSA, 
which reacts with gold exposed on the non-stamped components of the chip. This helps 
avoid any potential non-specific interactions between bacteria and the oxidized gold 
surface of the chip.45-47 The originally-stamped pattern of 15-BSA was indistinguishable 
from BSA used for blocking, but was observable in the following experiments by 
imaging S. aureus captured in the same pattern. 
 To determine the limit of detection (LoD) of this device, we exposed stamped 
chips to incrementally decreasing concentrations of S. aureus ranging from 1 x 106 
CFU/mL to 1 x 102 CFU/mL. Using dark field microscopy, we imaged the chips at 40x 
magnification. Figure 3.3 exhibits visible capture of S. aureus down to 1 x 102 CFU/mL. 
This data suggests that future applications of this device may enable early detection of S. 
aureus-related infections since pathogens can be effectively detected at early stages of 
population propagation without the necessity for pre-enrichment cultures.21 In addition to 
having a low limit of detection, the device also proved to capture the pathogen in an hour 
or less of exposure time, which is a vast improvement over other pathogen-detection 
methods like RT-PCR.48-50 Results of the time-course experiment are shown in figure 3.4. 
 Upon examination of the specificity of the chip when screened against a panel of 




(see figure 3.5). Aside from a low degree of cross reactivity exhibited with S. enterica,51 
our construct did not capture any of the other bacterial strains tested. The high degree of 
specificity that exists between compound 15 and S. aureus is an important characteristic 
that contributes to the simplicity and reproducibility of the assay by discriminating 
against false-positive results.  
  
3.5    Conclusion 
When taken together, the data collected from these experiments indicate that this 
device, which can selectively detect low concentrations of a S. aureus in minimal time, 
has enormous potential in the field of medicine. We expect that this device will accelerate 
the process of detecting S. aureus in our environment, and hope that it will contribute to 
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